{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Showdomycine : Questions médicales les plus fréquentes",
"headline": "Showdomycine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Showdomycine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-01",
"dateModified": "2025-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Showdomycine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Ribonucléosides",
"url": "https://questionsmedicales.fr/mesh/D012263",
"about": {
"@type": "MedicalCondition",
"name": "Ribonucléosides",
"code": {
"@type": "MedicalCode",
"code": "D012263",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.570.800"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Showdomycine",
"alternateName": "Showdomycin",
"code": {
"@type": "MedicalCode",
"code": "D012787",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Petja Rosenqvist",
"url": "https://questionsmedicales.fr/author/Petja%20Rosenqvist",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Turku, FIN-20500, Turku, Finland."
}
},
{
"@type": "Person",
"name": "Janne J Mäkinen",
"url": "https://questionsmedicales.fr/author/Janne%20J%20M%C3%A4kinen",
"affiliation": {
"@type": "Organization",
"name": "Department of Life Technologies, University of Turku, FIN-20014, Turku, Finland."
}
},
{
"@type": "Person",
"name": "Kaisa Palmu",
"url": "https://questionsmedicales.fr/author/Kaisa%20Palmu",
"affiliation": {
"@type": "Organization",
"name": "Department of Life Technologies, University of Turku, FIN-20014, Turku, Finland."
}
},
{
"@type": "Person",
"name": "Johanna Jokinen",
"url": "https://questionsmedicales.fr/author/Johanna%20Jokinen",
"affiliation": {
"@type": "Organization",
"name": "Department of Life Technologies, University of Turku, FIN-20014, Turku, Finland."
}
},
{
"@type": "Person",
"name": "Ranjit K Prajapati",
"url": "https://questionsmedicales.fr/author/Ranjit%20K%20Prajapati",
"affiliation": {
"@type": "Organization",
"name": "Department of Life Technologies, University of Turku, FIN-20014, Turku, Finland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Initiatives, Concepts, and Implementation Practices of the Findable, Accessible, Interoperable, and Reusable Data Principles in Health Data Stewardship: Scoping Review.",
"datePublished": "2023-08-28",
"url": "https://questionsmedicales.fr/article/37639292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2196/45013"
}
},
{
"@type": "ScholarlyArticle",
"name": "Equity and bias in electronic health records data.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37225122",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cct.2023.107238"
}
},
{
"@type": "ScholarlyArticle",
"name": "Data quality and autism: Issues and potential impacts.",
"datePublished": "2022-11-28",
"url": "https://questionsmedicales.fr/article/36455477",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijmedinf.2022.104938"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Detection of Date Shifting in Real-World Data.",
"datePublished": "2023-07-17",
"url": "https://questionsmedicales.fr/article/37459888",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2130-2197"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tailoring Rule-Based Data Quality Assessment to the Patient-Centered Outcomes Research Network (PCORnet) Common Data Model (CDM).",
"datePublished": "2023-04-29",
"url": "https://questionsmedicales.fr/article/37128433",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009705"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ribonucléosides",
"item": "https://questionsmedicales.fr/mesh/D012263"
},
{
"@type": "ListItem",
"position": 5,
"name": "Showdomycine",
"item": "https://questionsmedicales.fr/mesh/D012787"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Showdomycine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Showdomycine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Showdomycine",
"description": "Comment diagnostiquer une infection nécessitant la showdomycine ?\nQuels tests sont utilisés pour évaluer l'efficacité de la showdomycine ?\nQuels symptômes indiquent une infection bactérienne ?\nLa showdomycine est-elle utilisée pour toutes les infections ?\nQuels sont les critères de choix de la showdomycine ?",
"url": "https://questionsmedicales.fr/mesh/D012787?mesh_terms=Data+Accuracy&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Showdomycine",
"description": "Quels symptômes peuvent nécessiter l'utilisation de la showdomycine ?\nLa showdomycine provoque-t-elle des effets secondaires ?\nQuels signes d'allergie à la showdomycine ?\nComment reconnaître une surinfection ?\nLes symptômes d'une infection bactérienne sont-ils toujours évidents ?",
"url": "https://questionsmedicales.fr/mesh/D012787?mesh_terms=Data+Accuracy&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Showdomycine",
"description": "Comment prévenir les infections nécessitant la showdomycine ?\nLes antibiotiques préventifs sont-ils recommandés ?\nQuelles mesures d'hygiène sont essentielles ?\nLes vaccinations aident-elles à prévenir les infections ?\nComment éviter la résistance aux antibiotiques ?",
"url": "https://questionsmedicales.fr/mesh/D012787?mesh_terms=Data+Accuracy&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Showdomycine",
"description": "Comment la showdomycine est-elle administrée ?\nCombien de temps dure un traitement avec la showdomycine ?\nLa showdomycine peut-elle être combinée avec d'autres antibiotiques ?\nQuels sont les risques d'un traitement inapproprié avec la showdomycine ?\nLa showdomycine est-elle efficace contre toutes les bactéries ?",
"url": "https://questionsmedicales.fr/mesh/D012787?mesh_terms=Data+Accuracy&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Showdomycine",
"description": "Quelles complications peuvent survenir avec la showdomycine ?\nLa résistance bactérienne est-elle une complication de la showdomycine ?\nQuels sont les signes d'une réaction allergique grave ?\nComment gérer les effets secondaires de la showdomycine ?\nLes complications peuvent-elles affecter le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D012787?mesh_terms=Data+Accuracy&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Showdomycine",
"description": "Quels facteurs augmentent le risque d'infection ?\nL'âge influence-t-il le risque d'infection ?\nLes maladies chroniques augmentent-elles le risque d'infection ?\nLe mode de vie influence-t-il le risque d'infection ?\nLes voyages à l'étranger augmentent-ils le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D012787?mesh_terms=Data+Accuracy&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection nécessitant la showdomycine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures microbiologiques et des tests de sensibilité aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'efficacité de la showdomycine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de diffusion sur gélose et des tests de dilution en milieu liquide sont courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection bactérienne ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur, rougeur et gonflement au site d'infection sont des signes courants."
}
},
{
"@type": "Question",
"name": "La showdomycine est-elle utilisée pour toutes les infections ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, son utilisation est spécifique à certaines infections bactériennes sensibles."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de choix de la showdomycine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choix dépend de la souche bactérienne, de la gravité de l'infection et des antécédents du patient."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent nécessiter l'utilisation de la showdomycine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes d'infection comme fièvre, douleur localisée et inflammation peuvent indiquer son besoin."
}
},
{
"@type": "Question",
"name": "La showdomycine provoque-t-elle des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées, vomissements ou réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels signes d'allergie à la showdomycine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éruptions cutanées, démangeaisons, et œdème peuvent indiquer une allergie à ce médicament."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une surinfection ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une aggravation des symptômes initiaux ou l'apparition de nouveaux symptômes peut indiquer une surinfection."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une infection bactérienne sont-ils toujours évidents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent présenter des symptômes atypiques ou légers, rendant le diagnostic difficile."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections nécessitant la showdomycine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène, se faire vacciner et éviter les contacts avec des personnes malades."
}
},
{
"@type": "Question",
"name": "Les antibiotiques préventifs sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne sont généralement pas recommandés sauf dans des cas spécifiques, comme avant une chirurgie."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont essentielles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement, désinfecter les surfaces et éviter le partage d'objets personnels."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque d'infections bactériennes ciblées."
}
},
{
"@type": "Question",
"name": "Comment éviter la résistance aux antibiotiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser les antibiotiques uniquement lorsque nécessaire et suivre les prescriptions médicales."
}
},
{
"@type": "Question",
"name": "Comment la showdomycine est-elle administrée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement administrée par voie intraveineuse ou intramusculaire selon l'infection."
}
},
{
"@type": "Question",
"name": "Combien de temps dure un traitement avec la showdomycine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie de quelques jours à plusieurs semaines selon l'infection traitée."
}
},
{
"@type": "Question",
"name": "La showdomycine peut-elle être combinée avec d'autres antibiotiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être utilisée en association avec d'autres antibiotiques pour élargir le spectre d'action."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'un traitement inapproprié avec la showdomycine ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement inapproprié peut entraîner une résistance bactérienne et des complications graves."
}
},
{
"@type": "Question",
"name": "La showdomycine est-elle efficace contre toutes les bactéries ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, son efficacité est limitée à certaines souches bactériennes sensibles à cet antibiotique."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la showdomycine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des réactions allergiques sévères ou des troubles gastro-intestinaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "La résistance bactérienne est-elle une complication de la showdomycine ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une utilisation inappropriée peut entraîner une résistance, rendant le traitement moins efficace."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une réaction allergique grave ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Difficulté à respirer, gonflement du visage ou de la gorge, et éruption cutanée étendue sont des signes alarmants."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires de la showdomycine ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un médecin pour ajuster le traitement ou prescrire des médicaments pour soulager les effets secondaires."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter le traitement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications peuvent nécessiter un changement de traitement ou une hospitalisation."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un système immunitaire affaibli, le diabète et l'hospitalisation prolongée augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées et les jeunes enfants sont plus susceptibles de développer des infections."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le VIH, le diabète ou les maladies pulmonaires chroniques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire, le tabagisme et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions à forte prévalence d'infections peut augmenter le risque d'exposition."
}
}
]
}
]
}
Thorough data stewardship is a key enabler of comprehensive health research. Processes such as data collection, storage, access, sharing, and analytics require researchers to follow elaborate data man...
This scoping review identifies and discusses concepts, approaches, implementation experiences, and lessons learned in FAIR initiatives in health research data....
The Arksey and O'Malley stage-based methodological framework for scoping reviews was applied. PubMed, Web of Science, and Google Scholar were searched to access relevant publications. Articles written...
A total of 2.18% (34/1561) of the screened articles were included in the final review. The authors reported FAIRification approaches, which include interpolation, inclusion of comprehensive data dicti...
This work summarises projects, tools, and workflows for the FAIRification of health research data. The comprehensive review shows that implementing the FAIR concept in health data stewardship carries ...
RR2-10.2196/22505....
Embedded pragmatic clinical trials (ePCTs) are conducted during routine clinical care and have the potential to increase knowledge about the effectiveness of interventions under real world conditions....
Large healthcare datasets can provide insight that has the potential to improve outcomes for patients. However, it is important to understand the strengths and limitations of such datasets so that the...
Data were extracted from the HES database for the period 1st April 2013 to 31st March 2021 for patients with a diagnosis of autism. First spells in hospital during the study period were identified for...
Data were available for 172,324 unique patients who had been recorded as having an autism diagnosis on first admission. In total, 43.7 % of subsequent spells were found to have inconsistencies. The fe...
Data inconsistencies in the HES database were relatively common in autistic patients and were associated a number of patient and hospital admission characteristics. Such inconsistencies have the poten...
Analysis of health care real-world data (RWD) provides an opportunity to observe the actual patient diagnostic, treatment, and outcome events. However, researchers should understand the possible limit...
A methodology for detecting the presence of shifted dates in RWD was developed by considering various approaches to confirm the expected occurrences of medical events, including unique temporal occurr...
Twenty-eight of the 71 HCOs analyzed were predicted by methodology and confirmed by their data providers to have shifted data. Likewise, 39 were predicted and confirmed to not have shifted data. With ...
The presence of date shifting for U.S. HCOs may be reliably detected assessing whether the routine exams should always occur on weekdays....
Individual researchers and research networks have developed and applied different approaches to assess the data quality of electronic health record (EHR) data. A previously published rules-based metho...
The emergency department (ED) is pivotal in treating serious injuries, making it a valuable source for population-based injury surveillance. In Victoria, information that is relevant to injury surveil...
A retrospective observational study of administrative healthcare data....
VEMD and VAED data from July 2014 to June 2019 were compared. Including only hospitals contributing to both datasets, cases that (1) arrived at the ED and (2) were subsequently admitted, were selected...
While the overall number of cases was similar, VAED outnumbered VEMD cases (414 630 vs 404 608), suggesting potential under-reporting of injuries in the ED. Age-related differences indicated a relativ...
Injury cases were more numerous in the VAED than in the VEMD even though the number is expected to be equal based on case selection. Older patients were under-represented in the VEMD; this could partl...
Metabolomics based on high-resolution mass spectrometry has become a powerful technique in biomedical research. The development of various analytical tools and online libraries has promoted the identi...
As a national effort to better understand the current pandemic, three cohorts collect sociodemographic and clinical data from coronavirus disease 2019 (COVID-19) patients from different target populat...
The goal of this work is to assure high consistency of research data mapped to the GECCO data model. In particular, it aims at identifying contradictions within interdependent GECCO data items of the ...
All suitable data items from each of the three NAPKON cohorts are mapped to the GECCO items. A consistency assessment tool (dqGecco) is implemented, following the design of an existing quality assessm...
Our consistency assessment tool helped in correcting the mapping procedure and reveals remaining contradictory value combinations within COVID-19 symptoms, vital signs, and COVID-19 severity. Consiste...
An efficient and portable tool capable of discovering inconsistencies in the COVID-19 domain has been developed and applied to three different cohorts. As the GECCO dataset is employed in different pl...
In regard to health service planning and delivery, the use of information at different levels in the health system is vital, ranging from the influencing of policy to the programming of action to the ...
The five-stage approach of Arksey and O'Malley progressed by Levac et al. and Peters was followed. Three databases (PubMed, Web of Science and Embase) were searched, along with relevant conference pro...
Overall, DHIS2 data are being used but there are few detailed descriptions of this usage in peer reviewed or grey literature. We find that, commonly, there exists a centralised versus decentralised pa...
We conclude with some suggestions for a way forward, namely: i) the need to document in more detail and share how data are being used, ii) the need to investigate how data were created and who uses su...
Good quality data are a key to quality health care. In 2017, WHO has launched the Quality of Care Network (QCN) to reduce maternal, newborn and stillbirth mortality via learning and sharing networks. ...
This paper seeks to explore how QCN has contributed to improving data quality and to identify factors influencing quality of data in Ethiopia....
We conducted a qualitative study in selected QCN facilities in Ethiopia using key informant interview and observation methods. We interviewed 40 people at national, sub-national and facility levels. N...
There was a general perception that QCN had improved health data documentation and use in the learning facilities, achieved through coaching, learning and building from pre-existing initiatives. QCN a...
There is evidence of QCN's contribution to improving data awareness. But a lack of inclusive engagement of actors, alignment and limited skill for data collection and analysis continued to affect data...